Subtractive proteomic approach to the endometrial carcinoma invasion front

Journal of Proteome Research

Volumn 8, Issue 10, 2009, Pages 4676-4684

  Monge, Marta ^a   Doll, Andreas ^a   Colas, Eva ^a   Gil Moreno, Antonio ^a,b   Castellvi, Josep ^a,b   Garcia, Angel ^a,b   Colome, Nuria ^a   Perez Benavente, Asummpcio ^a   Pedrola, Nuria ^a   Lopez Lopez, Rafael ^c   Dolcet, Xavier ^d   Ramon Y Cajal, Santiago ^a,b   Xercavins, Jordi ^a,b   Matias Guiu, Xavier ^d   Canals, Francesc ^a   Reventos, Jaume ^a,b   Abal, Miguel ^a,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^d UNIVERSITY OF LLEIDA   (Spain)

Author keywords

2D DIGE; BLVRB; Endometrial carcinoma; Invasion front; Metastasis; SOD1; Subtractive proteomics

Indexed keywords

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER INVASION; CELL INFILTRATION; CELL INTERACTION; CELL MOTION; CELL STRUCTURE; CLINICAL ARTICLE; CLUSTER ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LASER MICRODISSECTION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AGED; CLUSTER ANALYSIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENDOMETRIAL NEOPLASMS; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PROTEINS; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE;

EID: 70349970657     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900390t     Document Type: Article

References (37)

1. Alaoui-Jamali, M. A.; Xu, Y. J. Proteomic technology for biomarker profiling in cancer: an update. J. Zhejiang Univ., Sci., B 2006, 7 (6), 411-420.
2. Dowling, P.; Walsh, N.; Clynes, M. Membrane and membrane-associated proteins involved in the aggressive phenotype displayed by highly invasive cancer cells. Proteomics 2008, 8 (19), 4054-4065.
3. Creasman, W. T.; Morrow, C. P.; Bundy, B. N.; Homesley, H. D.; Graham, J. E.; Heller, P. B. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987, 60 (8 Suppl.), 2035-2041.
4. Vardi, J. R.; Tadros, G. H.; Anselmo, M. T.; Rafla, S. D. The value of exploratory laparotomy in patients with endometrial carcinoma according to the new International Federation of Gynecology and Obstetrics staging. Obstet. Gynecol. 1992, 80 (2), 204-208.
5. Abal, M.; Llaurado, M.; Doll, A.; Monge, M.; Colas, E.; Gonzalez, M.; Rigau, M.; Alazzouzi, H.; Demajo, S.; Castellvi, J.; Garcia, A.; Ramon y Cajal, S.; Xercavins, J.; Vazquez-Levin, M. H.; Alameda, F.; Gil-Moreno, A.; Reventos, J. Molecular determinants of invasion in endometrial cancer. Clin. Transl. Oncol. 2007, 9 (5), 272-277.
6. Engelsen, I. B.; Mannelqvist, M.; Stefansson, I. M.; Carter, S. L.; Beroukhim, R.; Oyan, A. M.; Otte, A. P.; Kalland, K. H.; Akslen, L. A.; Salvesen, H. B. Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma. Br. J. Cancer 2008, 98 (10), 1662-1669.
7. Sivridis, E. Angiogenesis and endometrial cancer. Anticancer Res. 2001, 21 (6B), 4383-4388.
8. Tsukamoto, H.; Shibata, K.; Kajiyama, H.; Terauchi, M.; Nawa, A.; Kikkawa, F. Uterine smooth muscle cells increase invasive ability of endometrial carcinoma cells through tumor-stromal interaction. Clin. Exp. Metastasis 2007, 24 (6), 423-429. (Pubitemid 47367684)
9. Dunkley, T. P.; Watson, R.; Griffin, J. L.; Dupree, P.; Lilley, K. S. Localization of organelle proteins by isotope tagging (LOPIT). Mol. Cell. Proteomics 2004, 3 (11), 1128-1134.
10. Yan, W.; Aebersold, R.; Raines, E. W. Evolution of organelle-associated protein profiling. J. Proteomics 2009, 72 (1), 4-11.
11. Alban, A.; David, S. O.; Bjorkesten, L.; Andersson, C.; Sloge, E.; Lewis, S.; Currie, I. A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 2003, 3 (1), 36-44. (Pubitemid 36151066)
12. Shevchenko, A.; Wilm, M.; Vorm, O.; Mann, M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68 (5), 850-858. (Pubitemid 26101214)
13. Esselens, C. W.; Malapeira, J.; Colome, N.; Moss, M.; Canals, F.; Arribas, J. Metastasis-associated C4.4A, a GPI-anchored protein cleaved by ADAM10 and ADAM17. Biol. Chem. 2008, 389 (8), 1075-1084.
14. Monge, M.; Colas, E.; Doll, A.; Gonzalez, M.; Gil-Moreno, A.; Planaguma, J.; Quiles, M.; Arbos, M. A.; Garcia, A.; Castellvi, J.; Llaurado, M.; Rigau, M.; Alazzouzi, H.; Xercavins, J.; Alameda, F.; Reventos, J.; Abal, M. ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer. Cancer Res. 2007, 67 (14), 6753-6759.
15. Deighton, R. F.; Short, D. M.; McGregor, R. J.; Gow, A. J.; Whittle, I. R.; McCulloch, J. The utility of functional interaction and cluster analysis in CNS proteomics. J. Neurosci. Methods 2009, 180 (2), 321-329.
16. Fridovich, I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 1995, 64, 97-112.
17. Florczyk, U. M.; Jozkowicz, A.; Dulak, J. Biliverdin reductase: new features of an old enzyme and its potential therapeutic significance. Pharmacol. Rep. 2008, 60 (1), 38-48. (Pubitemid 351586541)
18. Yates, J. R., 3rd; Gilchrist, A.; Howell, K. E.; Bergeron, J. J. Proteomics of organelles and large cellular structures. Nat. Rev. Mol. Cell Biol. 2005, 6 (9), 702-714.
19. Paweletz, C. P.; Charboneau, L.; Bichsel, V. E.; Simone, N. L.; Chen, T.; Gillespie, J. W.; Emmert-Buck, M. R.; Roth, M. J.; Petricoin, I. E.; Liotta, L. A. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 2001, 20 (16), 1981-1989.
20. Greengauz-Roberts, O.; Stoppler, H.; Nomura, S.; Yamaguchi, H.; Goldenring, J. R.; Podolsky, R. H.; Lee, J. R.; Dynan, W. S. Saturation labeling with cysteine-reactive cyanine fluorescent dyes provides increased sensitivity for protein expression profiling of laser-microdissected clinical specimens. Proteomics 2005, 5 (7), 1746-1757.
21. Rodriguez, A. S.; Espina, B. H.; Espina, V.; Liotta, L. A. Automated laser capture microdissection for tissue proteomics. Methods Mol. Biol. 2008, 441, 71-90.
22. Wilson, K. E.; Marouga, R.; Prime, J. E.; Pashby, D. P.; Orange, P. R.; Crosier, S.; Keith, A. B.; Lathe, R.; Mullins, J.; Estibeiro, P.; Bergling, H.; Hawkins, E.; Morris, C. M. Comparative proteomic analysis using samples obtained with laser microdissection and saturation dye labelling. Proteomics 2005, 5 (15), 3851-3858.
23. Kondo, T.; Hirohashi, S. Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics. Nat. Protoc. 2006, 1 (6), 2940-2956.
24. Doi, D.; Araki, T.; Asano, G. Immunohistochemical localization of tenascin, estrogen receptor and transforming growth factor-beta 1 in human endometrial carcinoma. Gynecol. Obstet. Invest. 1996, 41 (1), 61-66. (Pubitemid 26021656)
25. Sivridis, E.; Giatromanolaki, A.; Koukourakis, M. I.; Bicknell, R.; Harris, A. L.; Gatter, K. C. Thymidine phosphorylase expression in endometrial carcinomas. Clin. Exp. Metastasis 1999, 17 (5), 445-450. (Pubitemid 30020003)
26. Sedlmayr, P.; Semlitsch, M.; Gebru, G.; Karpf, E.; Reich, O.; Tang, T.; Wintersteiger, R.; Takikawa, O.; Dohr, G. Expression of indoleamine 2,3-dioxygenase in carcinoma of human endometrium and uterine cervix. Adv. Exp. Med. Biol. 2003, 527, 91-95. (Pubitemid 38197632)
27. Vignjevic, D.; Schoumacher, M.; Gavert, N.; Janssen, K. P.; Jih, G.; Lae, M.; Louvard, D.; Ben-Ze'ev, A.; Robine, S. Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res. 2007, 67 (14), 6844-6853.
28. Wu, W. S. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev. 2006, 25 (4), 695-705.
29. Nimnual, A. S.; Taylor, L. J.; Bar-Sagi, D. Redox-dependent downregulation of Rho by Rac. Nat. Cell Biol. 2003, 5 (3), 236-241.
30. Storz, P. Reactive oxygen species in tumor progression. Front. Biosci. 2005, 10, 1881-1896. (Pubitemid 40529044)
31. Lee, K. J.; Hwang, S. J.; Choi, J. H.; Jeong, H. G. Saponins derived from the roots of Platycodon grandiflorum inhibit HT-1080 cell invasion and MMPs activities: regulation of NF-kappaB activation via ROS signal pathway. Cancer Lett. 2008, 268 (2), 233-243.
32. Park, M. J.; Lee, J. Y.; Kwak, H. J.; Park, C. M.; Lee, H. C.; Woo, S. H.; Jin, H. O.; Han, C. J.; An, S.; Lee, S. H.; Chung, H. Y.; Park, I. C.; Hong, S. I.; Rhee, C. H. Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species. J. Cell. Biochem. 2005, 95 (5), 955-969.
33. Kim, K. H.; Cho, Y. S.; Park, J. M.; Yoon, S. O.; Kim, K. W.; Chung, A. S. Pro-MMP-2 activation by the PPARgamma agonist, ciglitazone, induces cell invasion through the generation of ROS and the activation of ERK. FEBS Lett. 2007, 581 (17), 3303-3310.
34. Kim, M. H.; Cho, H. S.; Jung, M.; Hong, M. H.; Lee, S. K.; Shin, B. A.; Ahn, B. W.; Jung, Y. D. Extracellular signal-regulated kinase and AP-1 pathways are involved in reactive oxygen species-induced urokinase plasminogen activator receptor expression in human gastric cancer cells. Int. J. Oncol. 2005, 26 (6), 1669-1674.
35. Monge, M.; Colas, E.; Doll, A.; Gil-Moreno, A.; Castellvi, J.; Diaz, B.; Gonzalez, M.; Lopez-Lopez, R.; Xercavins, J.; Carreras, R.; Alameda, F.; Canals, F.; Gabrielli, F.; Reventos, J.; Abal, M. Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress. Carcinogenesis 2009, 30 (8), 1288-1297.
36. Llobet, D.; Eritja, N.; Encinas, M.; Sorolla, A.; Yeramian, A.; Schoenenberger, J. A.; Llombart-Cussac, A.; Marti, R. M.; Matias-Guiu, X.; Dolcet, X. Antioxidants block proteasome inhibitor function in endometrial carcinoma cells. Anti-Cancer Drugs 2008, 19 (2), 115-124.
37. Abal, M.; Planaguma, J.; Gil-Moreno, A.; Monge, M.; Gonzalez, M.; Baro, T.; Garcia, A.; Castellvi, J.; Ramon, Y. C. S.; Xercavins, J.; Alameda, F.; Reventos, J. Molecular pathology of endometrial carcinoma: transcriptional signature in endometrioid tumors. Histol. Histopathol. 2006, 21 (2), 197-204. (Pubitemid 43033728)